Johanson JF - Search Results

1

Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies.

Johanson JF. Johanson JF. Neurogastroenterol Motil. 2004 Dec;16(6):701-11. doi: 10.1111/j.1365-2982.2004.00550.x. Neurogastroenterol Motil. 2004. PMID: 15601419 Review.

2

Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation.

Chey WD, Drossman DA, Johanson JF, Scott C, Panas RM, Ueno R. Chey WD, et al. Among authors: johanson jf. Aliment Pharmacol Ther. 2012 Mar;35(5):587-99. doi: 10.1111/j.1365-2036.2011.04983.x. Epub 2012 Jan 18. Aliment Pharmacol Ther. 2012. PMID: 22251419 Free article. Clinical Trial.

3

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.

Drossman DA, Chey WD, Johanson JF, Fass R, Scott C, Panas R, Ueno R. Drossman DA, et al. Among authors: johanson jf. Aliment Pharmacol Ther. 2009 Feb 1;29(3):329-41. doi: 10.1111/j.1365-2036.2008.03881.x. Epub 2008 Nov 4. Aliment Pharmacol Ther. 2009. PMID: 19006537 Free article. Clinical Trial.

4

Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety.

Johanson JF, Ueno R. Johanson JF, et al. Aliment Pharmacol Ther. 2007 Jun 1;25(11):1351-61. doi: 10.1111/j.1365-2036.2007.03320.x. Aliment Pharmacol Ther. 2007. PMID: 17509103 Clinical Trial.

5

Chronic constipation: a survey of the patient perspective.

Johanson JF, Kralstein J. Johanson JF, et al. Aliment Pharmacol Ther. 2007 Mar 1;25(5):599-608. doi: 10.1111/j.1365-2036.2006.03238.x. Aliment Pharmacol Ther. 2007. PMID: 17305761

6

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.

Johanson JF, Drossman DA, Panas R, Wahle A, Ueno R. Johanson JF, et al. Aliment Pharmacol Ther. 2008 Apr;27(8):685-96. doi: 10.1111/j.1365-2036.2008.03629.x. Epub 2008 Jan 28. Aliment Pharmacol Ther. 2008. PMID: 18248656 Clinical Trial.

7

Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.

Olden K, DeGarmo RG, Jhingran P, Bagby B, Decker C, Markowitz M, Carter E, Bobbitt W, Dahdul A, DeCastro E, Gringeri L, Johanson J, Levinson L, Mula G, Poleynard G, Stoltz RR, Truesdale R, Young D; Lotronex Investigator Team. Olden K, et al. Am J Gastroenterol. 2002 Dec;97(12):3139-46. doi: 10.1111/j.1572-0241.2002.07111.x. Am J Gastroenterol. 2002. PMID: 12492201 Clinical Trial.

8

An improved approach to delivery of enteral nutrition in the intensive care unit.

Baskin WN, Johanson JF. Baskin WN, et al. Among authors: johanson jf. Gastrointest Endosc. 1995 Aug;42(2):161-5. doi: 10.1016/s0016-5107(95)70074-9. Gastrointest Endosc. 1995. PMID: 7590053 No abstract available.

9

Diagnosis and management of AIDS-related diarrhea.

Johanson JF. Johanson JF. Can J Gastroenterol. 1996 Nov-Dec;10(7):461-8. doi: 10.1155/1996/739845. Can J Gastroenterol. 1996. PMID: 9113890 Review.

10

Review article: tegaserod for chronic constipation.

Johanson JF. Johanson JF. Aliment Pharmacol Ther. 2004 Nov;20 Suppl 7:20-4. doi: 10.1111/j.1365-2036.2004.02187.x. Aliment Pharmacol Ther. 2004. PMID: 15521851 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results